Resources for quality and supplier risk management

An industry first, specially designed with quality, procurement and operations teams in mind.

Hidden Risk in the Supplier Portfolio

Discover how Supplier Risk Concentration builds in pharma portfolios — why static assessments fail & how continuous monitoring reveals hidden...
Hidden Risk in the Supplier Portfolio - Discover how supplier risk concentrates across sites, evolves over time, and remains fragmented across systems, and how continuous monitoring can reveal risk exposure before it escalates
101 results
Checkbox | Topic Tags
Cover for The Complete Guide to Supplier Qualification in 2026
Guides and whitepapers

The Complete Guide to Supplier Qualification in 2026

Build resilience. Strengthen trust. Lead the next era of supplier qualification. In a rapidly evolving pharmaceutical landscape, supplier qualification is...

Woman working from home participating in a video conference call with multiple colleagues on screen
Product Updates

We’re sorry you can’t make it this time. We’ll miss having you at this session

We hope to see you at one of our upcoming webinars!...
Woman working from home participating in a video conference call with multiple colleagues on screen
Product Updates

Thank you for confirming your attendance! We’re excited to have you join us

In October, Sandra Lopes Guerreiro showed us in the webinar “From Rigid to Resilient: Agile Audit Planning in Pharma” why...

calendar_month
Upcoming event
Woman working from home participating in a video conference call with multiple colleagues on screen
Events and webinars

Online Meetup: Agile Audit Planning

In October, Sandra Lopes Guerreiro showed us in the webinar “From Rigid to Resilient: Agile Audit Planning in Pharma” why...

Qualifyze and Noucor partnership banner featuring a smiling scientist holding a tablet in a lab.
Casos prácticos

Case Study: Noucor & Qualifyze Quality Standards

Scientist using pipette with digital medical data overlay representing advanced healthcare research.
Blog

U.S. Tariffs Impact on Pharma Supply Chains

Starting October 1, branded pharmaceuticals imported into the U.S. will face a 100 % tariff. Generics are excluded — at...